Clinical Trials Directory

Trials / Completed

CompletedNCT01722864

Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)

An Open Label Safety Study of COV155 in Subjects With Osteoarthritis or Chronic Low Back Pain

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
153 (actual)
Sponsor
Mallinckrodt · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A study to show the safety of COV155 in patients with osteoarthritis of the knee or hip or moderate to severe chronic low back pain.

Conditions

Interventions

TypeNameDescription
DRUGCOV155COV155 tablets

Timeline

Start date
2012-11-01
Primary completion
2013-02-01
Completion
2013-08-01
First posted
2012-11-07
Last updated
2016-10-19

Locations

34 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01722864. Inclusion in this directory is not an endorsement.